Methylene blue (Basic Blue 9) 是一种鸟苷酸环化酶 (sGC),单胺氧化酶 A (MAO-A)和 NO 合酶 (NOS) 抑制剂。Methylene blue 是一种血管加压剂,在医疗中通常用作染料。Methylene blue 具有抗伤害感受,抗疟疾,抗抑郁和抗焦虑作用,可用于高铁血红蛋白血症,神经退行性疾病和异环磷酰胺引起的脑病的研究。 Methy...
Structure-based optimization of FDA-approved drug methylene blue as a c-myc G-quadruplex DNA stabilizer. Biochimie 2011; 93: 1055-64.Chan DS-H, Yang H, Kwan MH-T, Cheng Z, Lee P, Bai L-P, et al. Structure-based optimization of FDA-approved drug methylene blue as a c-myc G-...
Methylene blue trihydrate 是一种血管加压药,在医疗中通常用作染料。Methylene blue trihydrate 具有抗伤害感受,抗疟疾,抗抑郁和抗焦虑作用,可用于高铁血红蛋白血症,神经退行性疾病和异环磷酰胺引起的脑病的研究。 研究领域:GPCR/G Protein | Neuronal Signaling | Immunology/Inflammation | Anti-infection 作用靶点:...
伊红美蓝琼脂(EMB)英文名称:Eosin-Methylene Blue Agar 伊红美蓝琼脂(EMB)用途:弱选择性培养基、用于分离肠道致病菌,特别是大肠杆菌(GB、SN标准) 伊红美蓝琼脂(EMB)规格:250g 成分(g/L) 蛋白胨 10.0 乳糖 10.0 磷酸氢二钾 2.0 琼脂 15.0 伊红 0.4
Structure-based optimization of FDA-approved drug methylene blue as a c-myc G-quadruplex DNA stabilizer. Biochimie 2011; 93: 1055-64.Chan DSH, Yang H, Kwan MHT, Cheng Z, Lee P, Bai LP, Jiang ZH, Wong CY, Fong WF, Leung CH, et al. Structure-based optimization of FDA-approved drug...
伊红美蓝琼脂(EMB)(颗粒)英文名称:Eosin-Methylene Blue Agar 伊红美蓝琼脂(EMB)(颗粒)用途:弱选择性培养基,用于肠道菌的选择性分离 伊红美蓝琼脂(EMB)(颗粒)规格:250g 伊红美蓝琼脂(EMB)(颗粒)用法: 称取本品 37.4g,加热搅拌溶解于 1000ml 蒸馏水中,分装三角瓶,121℃高压灭菌 15 分钟,备用。
曙红亚甲基蓝琼脂培养基(EMB) Eosin-Methylene Blue Agar HB7010 250g 价格￥160 起批量≥1瓶 最小起订1瓶 供货总量999瓶 发货地址山东省青岛市 建议售价￥160/瓶 更新日期2024年12月27日 产品规格250g 即时洽谈立即询价查看联系方式 收藏产品发送留言 ...
An increase in CA concentration from 1 to 2 wt% led to the high removal of methylene blue (MB). The highest removal of MB (90.90%) was obtained by TiO2/Ag/CA under the conditions of 4 g/L catalyst loading, 5 ppm MB concentration, and at unadjusted pH (7.8). The recyclability ...
Methylene blue (MB) is an FDA-approved drug used to treat cyanide poisoning, carbon monoxide poisoning, and methemoglobinemia [24]. It has been shown to attenuate pathological and neurobehavioral impairments in animal models of Alzheimer’s disease, Parkinson’s disease, and ischemic stroke [25]...